21 off-therapy ALL patients treated with chemotherapy plus cranial irradiation were assessed using the Wechsler Intelligence Scale for Children and compared with a group of 15 off-therapy solid tumor children treated with chemotherapy and extracranial irradiation. Children with leukemia achieved lower IQ scores than children with solid tumors. The ALL group was divided in two subgroups, by onset of disease and beginning of treatment: before (13 subjects) and after (8 subjects) 5 years of age. The results indicate that the disturbance of intellectual functioning is produced in ALL children irradiated after 5 years of age. In order to check on a possible delayed intellectual deterioration, all ALL children were also tested twice, with one year interval between the two tests. On the second assessment the scores for each subject were essentially the same as before. Further studies on a large number of long term survivors are being carried out in order to find out whether the deficit is transient or permanent.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02331038DOI Listing

Publication Analysis

Top Keywords

treated chemotherapy
8
years age
8
children
6
intellectual function
4
function long-term
4
long-term survivors
4
survivors childhood
4
childhood acute
4
acute lymphoblastic
4
lymphoblastic leukemia
4

Similar Publications

Myocardial infarction can lead to the loss of billions of cardiomyocytes, and while cell-based therapies are an option, immature nature of in vitro-generated human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iCMs) is a roadblock to their development. Existing iPSC differentiation protocols don't go beyond producing fetal iCMs. Recently, adult extracellular matrix (ECM) was shown to retain tissue memory and have some success driving tissue-specific differentiation in unspecified cells in various organ systems.

View Article and Find Full Text PDF

Background: Tegoprazan (TPZ), a potassium-competitive acid blocker with potent gastric acid-suppressing activity, may be a potential agent for treating Helicobacter pylori infection. The study aimed to evaluate the efficacy of TPZ-based therapy for H. pylori eradication compared with proton pump inhibitor (PPI)-based therapy.

View Article and Find Full Text PDF

Therapeutic drug development for central nervous system injuries, such as traumatic brain injury (TBI), presents significant challenges. TBI results in primary mechanical damage followed by secondary injury, leading to cognitive dysfunction and memory loss. Our recent study demonstrated the potential of carbon monoxide-releasing molecules (CORMs) to improve TBI recovery by enhancing neurogenesis.

View Article and Find Full Text PDF

Efficient and Rapid Generation of Neural Stem Cells by Direct Conversion Fibroblasts with Single microRNAs.

Stem Cells

January 2025

Medicine and Pharmacy Research Center, and Yantai Key Laboratory for Stem Cell Biology and Regenerative Medicine, Binzhou Medical University, 346 Guanhai Road, Yantai, Shandong 264003, China.

Neural stem cells (NSCs) have great potentials in the application of neurodegenerative disease therapy, drug screening, and disease modeling. However, current approaches for induced NSCs (iNSCs) generation from somatic cells are still slow and inefficient. Here we establish a rapid and efficient method of iNSCs generation from human and mouse fibroblasts by single microRNAs (miR-302a).

View Article and Find Full Text PDF

Background: HIV remains a major challenge in KwaZulu-Natal, South Africa, particularly for young women who face disproportionate risks and barriers to prevention and treatment. Most HIV cure trials, however, occur in high-income countries.

Objective: To examine the perspectives of young women diagnosed with acute HIV in a longitudinal study, focusing on their perceptions on ATI-inclusive HIV cure trials and the barriers and facilitators to participation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!